SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-039726
Filing Date
2020-07-01
Accepted
2020-07-01 16:16:16
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3733
  Complete submission text file 0001209191-20-039726.txt   5087
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Issuer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS 399 BINNEY STREET SUITE 300 CAMBRIDGE MA 02139
Business Address
Prener Anne (Reporting) CIK: 0001797917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38822 | Film No.: 201005533